Label: ADENOSINE injection

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 6, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    SAGENT - ® Rx only
  • Description
    Adenosine is an endogenous nucleoside occurring in all cells of the body. It is chemically 6-amino-9-β-D-ribofuranosyl-9-H-purine and has the following structural formula: Adenosine is a white ...
  • Clinical Pharmacology
    Mechanism of Action - Adenosine Injection slows conduction time through the A-V node, can interrupt the reentry pathways through the A-V node, and can restore normal sinus rhythm in patients with ...
  • Contraindications
    Intravenous adenosine injection is contraindicated in: Second- or third-degree A-V block (except in patients with a functioning artificial pacemaker). Sinus node disease, such as sick sinus ...
  • Warnings
    Heart Block - Adenosine Injection exerts its effect by decreasing conduction through the A-V node and may produce a short lasting first-, second- or third-degree heart block. Appropriate therapy ...
  • Precautions
    Drug Interactions - Intravenous adenosine injection has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium ...
  • Adverse Reactions
    The following reactions were reported with intravenous adenosine injection used in controlled U.S. clinical trials. The placebo group had a less than 1% rate of all of these ...
  • Overdosage
    The half-life of adenosine injection is less than 10 seconds. Thus, adverse effects are generally rapidly self-limiting. Treatment of any prolonged adverse effects should be individualized and be ...
  • Dosage and Administration
    For rapid bolus intravenous use only. Adenosine Injection, USP should be given as a rapid bolus by the peripheral intravenous route. To be certain the solution reaches the systemic circulation ...
  • How Supplied
    Adenosine Injection, USP is supplied as a sterile non-pyrogenic solution in normal saline. NDC: 70518-4207-00 - NDC: 70518-4207-01 - NDC: 70518-4207-02 - NDC: 70518-4207-03 - OUTER PACKAGING: 10 in 1 ...
  • REFERENCE
    Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
  • PRINCIPAL DISPLAY PANEL
    DRUG: Adenosine - GENERIC: Adenosine - DOSAGE: INJECTION - ADMINSTRATION: INTRAVENOUS - NDC: 70518-4207-0 - NDC: 70518-4207-1 - NDC: 70518-4207-2 - NDC: 70518-4207-3 - PACKAGING: 1 (2 mL in 1 VIAL) OUTER ...
  • INGREDIENTS AND APPEARANCE
    Product Information